ArticleAsian/Pacific Island nursing journal2019
A Review of Technology-based Interventions in Improving Type 2 Diabetes Management in Chinese Americans.
Article in Asian/Pacific Island nursing journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 11 citations in OpenAlex.
- Family-Based, Culturally Responsive Intervention for Chinese Americans With Diabetes: Lessons Learned From a Literature Review to Inform Study Design and Implementation.Asian/Pacific Island nursing journal · 2023Review
- A Social Media-Based Diabetes Intervention for Low-Income Mandarin-Speaking Chinese Immigrants in the United States: Feasibility Study.JMIR formative research · 2022Article
- Chinese Americans' Use of Patient Portal Systems: Scoping Review.JMIR human factors · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Health disparities of type 2 diabetes (DM2) in America is an ongoing crisis. Despite this, technology has been helpful in managing DM2 in the non-Hispanic White, Hispanic, and African American populations and has been proven effective. Furthermore, it may be used to supplement health provider DM2 care through telemedicine to lower hemoglobin A1c (A1c), a gold standard DM2 measurement, and other DM2-related outcomes, such as glycated hemoglobin. The purpose of this study was to review current literature on the use of telemedicine in assisting DM2 management in racial ethnic minorities and to discuss how to adjust the telemedicine DM2 management program to be applied to Chinese Americans. In addition, it is worthy to note that the role of nurses makes a substantial difference in the effectiveness of technological management of DM2 from being culturally sensitive and sending catered messages to address specific patient needs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.